81 reports of this reaction
4.0% of all NORETHINDRONE AND ETHINYL ESTRADIOL reports
#2 most reported adverse reaction
HEADACHE is the #2 most commonly reported adverse reaction for NORETHINDRONE AND ETHINYL ESTRADIOL, manufactured by Teva Pharmaceuticals USA, Inc.. There are 81 FDA adverse event reports linking NORETHINDRONE AND ETHINYL ESTRADIOL to HEADACHE. This represents approximately 4.0% of all 2,014 adverse event reports for this drug.
Patients taking NORETHINDRONE AND ETHINYL ESTRADIOL who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among NORETHINDRONE AND ETHINYL ESTRADIOL users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for NORETHINDRONE AND ETHINYL ESTRADIOL:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 81 FDA reports for NORETHINDRONE AND ETHINYL ESTRADIOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 4.0% of all adverse event reports for NORETHINDRONE AND ETHINYL ESTRADIOL, making it one of the most commonly reported side effect.
If you experience headache while taking NORETHINDRONE AND ETHINYL ESTRADIOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.